SEC Form SC 13G/A filed by Yumanity Therapeutics Inc. (Amendment)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
| Kineta, Inc. | 
| (Name of Issuer) | 
| Common Stock, par value $0.001 per share | 
| (Title of Class of Securities) | 
| 49461C 102 | 
| (CUSIP Number) | 
| December 31, 2023 | 
| (Date of Event which Requires Filing of this Statement) | 
| CUSIP No. 49461C 102 | ||||
| 1 | NAMES OF REPORTING PERSONS | |||
| Charles Magness | ||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | |||
| (a) ☐ (b) ☐ | ||||
| 3 | SEC USE ONLY | |||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION | |||
| U.S.A. | ||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: | 5 | SOLE VOTING POWER | ||
| 613,254 | ||||
| 6 | SHARED VOTING POWER | |||
| 7,159* | ||||
| 7 | SOLE DISPOSITIVE POWER | |||
| 613,254 | ||||
| 8 | SHARED DISPOSITIVE POWER | |||
| 7,159* | ||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |||
| 620,413 | ||||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | |||
| ☐ | ||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | |||
| 6.1%** | ||||
| 12 | TYPE OF REPORTING PERSON | |||
| IN | ||||
| Dated: February 12, 2024 | CHARLES MAGNESS | 
| /s/ Charles Magness | |